NCT00241150View on ClinicalTrials.gov

Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
HypertensionMetabolic Syndrome
Interventions
DRUG

VALSARTAN

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY